Diagnosis of small cell lung cancer by Pro Gastrin Releasing Peptide (ProGRP)

LaboratoriumsMedizin

Volumn 27, Issue 1-2, 2003, Pages 26-30

  Yamaguchi, K ^a   Stieber, Petra ^b,c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Lung cancer; ProGRP; SCLC; Small cell; Tumor marker

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; PEPTIDE HORMONE; PROGASTRIN RELEASING PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; HUMAN; INTERMETHOD COMPARISON; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PATHOPHYSIOLOGY; PROTEIN SECRETION;

AMPHIBIA; MAMMALIA; SUIDAE;

EID: 0037233899     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2003.006     Document Type: Article

References (10)

1. Yamaguchi K, Abe K, Kamoya T, Adachi I, Taguchi S, Otsubo K, Yanaihura N. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 1983;43(8):3932-3939.
2. McDonald TJ, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V. A gastrin releasing peptide from the porcine non-antral gastric tissue. Gut 1978;19:767-774.
3. Maruno K, Yamaguchi K, Abe K, Suzuki M, Saijo N, Mishima Y, Yanaihara N, Shimosato J. Immunoreactive gastrin releasing peptide as a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1989;49:629-632.
4. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K. Enzyme immunoassay of immunoreactive progastrin-releasing peptide (31-98) as tumor marker for small-cell lung carcinoma: development and evaluation. Clin Chem 1995; 41(4):537-543.
5. Miyake Y, Kodama T, Yamaguchi K. Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54(8):2136-2140.
6. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K. Pro-gastrin-releasing peptide (ProGRP) - a useful marker in small cell lung carcinomas. Anticancer Res 1999;19(4A):2673-2678.
7. Inaji H, Komoike Y, Motomura K, Higashiyama M, Ohtsuru M, Funai H, Kasugai T, Koyama H. Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma. Oncology 2000;59(2):122-125.
8. Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M. Complementary roles of progastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer 2001;32(1):61-69.
9. Lamy P, Grenier J, Kramar A, Pujol JL. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer 2000;29(3):197-203.
10. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung: cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer 2000;27(3):159-167.